Research graph
References from A novel method to identify and characterize personalized functional driver lncRNAs in cancer samples. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.biopha.2020.111158
10.1016/j.biopha.2020.111158 · External reference
10.1038/ng.3192
10.1038/ng.3192 · External reference
10.1158/0008-5472.can-16-2634
10.1158/0008-5472.can-16-2634 · External reference
lncRNAfunc: a knowledgebase of lncRNA function in human cancer
10.1093/nar/gkab1035 · 2022 · External reference
Molecular Mechanism of the Canonical Oncogenic lncRNA MALAT1 in Gastric Cancer
2021 · External reference
10.1038/nature22992
10.1038/nature22992 · External reference
Comprehensive Characterization of Cancer Driver Genes and Mutations
10.1016/j.cell.2018.02.060 · 2018 · External reference
10.1093/bioinformatics/bty006
10.1093/bioinformatics/bty006 · External reference
Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion
10.1083/jcb.201908078 · 2020 · External reference
10.1016/j.ccr.2014.07.009
10.1016/j.ccr.2014.07.009 · External reference
10.4143/crt.2017.307
10.4143/crt.2017.307 · External reference
10.1038/s41580-020-00315-9
10.1038/s41580-020-00315-9 · External reference
10.1093/nar/gkv1023
10.1093/nar/gkv1023 · External reference
10.1039/c4mb00289j
10.1039/c4mb00289j · External reference
Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer
10.1093/bib/bbz113 · 2020 · External reference
The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
2015 · External reference
10.1093/nar/gkj067
10.1093/nar/gkj067 · External reference
10.1016/j.ejca.2008.10.026
10.1016/j.ejca.2008.10.026 · External reference
The immune landscape of cancer
10.1016/j.immuni.2018.03.023 · 2018 · External reference
starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data
2014 · External reference
10.1093/nar/gkt1181
10.1093/nar/gkt1181 · External reference
10.1093/nar/gkq1027
10.1093/nar/gkq1027 · External reference
RNAInter in 2020: RNA interactome repository with increased coverage and annotation
10.1093/nar/gkz804 · 2020 · External reference
LncACTdb 2.0: an updated database of experimentally supported ceRNA interactions curated from low- and high-throughput experiments
10.1093/nar/gky1144 · 2019 · External reference
10.1186/1752-0509-6-92
10.1186/1752-0509-6-92 · External reference
Human Protein Reference Database--2009 update
10.1093/nar/gkn892 · 2009 · External reference
10.1101/gr.133991.111
10.1101/gr.133991.111 · External reference
10.1038/75556
10.1038/75556 · External reference
Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data
10.1093/nar/gkaa1006 · 2021 · External reference
10.1371/journal.pone.0080306
10.1371/journal.pone.0080306 · External reference
10.1101/gr.135350.111
10.1101/gr.135350.111 · External reference
10.1093/bioinformatics/btl633
10.1093/bioinformatics/btl633 · External reference
10.1016/j.ajhg.2008.02.013
10.1016/j.ajhg.2008.02.013 · External reference
10.1093/bioinformatics/btv417
10.1093/bioinformatics/btv417 · External reference
Topologically inferring risk-active pathways toward precise cancer classification by directed random walk
10.1093/bioinformatics/btt373 · 2013 · External reference
10.1093/bioinformatics/btq108
10.1093/bioinformatics/btq108 · External reference
Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways
10.1093/nar/gkt161 · 2013 · External reference
SubpathwayMiner: a software package for flexible identification of pathways
10.1093/nar/gkp667 · 2009 · External reference
GSVA: gene set variation analysis for microarray and RNA-seq data
10.1186/1471-2105-14-7 · 2013 · External reference
10.1093/bioinformatics/btq170
10.1093/bioinformatics/btq170 · External reference
A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma
10.1002/jcb.29164 · 2019 · External reference
KDM1A identified as a potential oncogenic driver and prognostic biomarker via multi-omics analysis
2021 · External reference
DriverDBv3: a multi-omics database for cancer driver gene research
2020 · External reference
10.1038/nrc2946
10.1038/nrc2946 · External reference
10.1073/pnas.162471999
10.1073/pnas.162471999 · External reference
10.1371/journal.pgen.1003201
10.1371/journal.pgen.1003201 · External reference
10.1213/ane.0000000000002864
10.1213/ane.0000000000002864 · External reference
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
10.1016/j.cell.2018.03.022 · 2018 · External reference
Knockdown of long noncoding RNA DLX6-AS1 inhibits migration and invasion of thyroid cancer cells by upregulating UPF1
2020 · External reference
Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer
2020 · External reference
Vascular endothelial growth factor signaling in development and disease
2018 · External reference
Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma
10.1002/jcb.29218 · 2020 · External reference
Diagnostic model of combined ceRNA and DNA methylation related genes in esophageal carcinoma
10.7717/peerj.8831 · 2020 · External reference
10.1016/j.omtn.2019.08.004
10.1016/j.omtn.2019.08.004 · External reference
10.1038/nrd4140
10.1038/nrd4140 · External reference
10.1038/nrd4018
10.1038/nrd4018 · External reference
RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data
10.1093/bib/bbz142 · 2020 · External reference
Retraction Note: HDAC6 inhibitor TST strengthens the antiproliferative effects of PI3K/mTOR inhibitor BEZ235 in breast cancer cells via suppressing RTK activation
10.1038/s41419-019-1866-9 · 2019 · External reference
Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models
10.1158/1078-0432.ccr-15-0187 · 2016 · External reference
10.3892/or.2015.4360
10.3892/or.2015.4360 · External reference
10.1074/jbc.m109.006676
10.1074/jbc.m109.006676 · External reference
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy
10.1093/neuonc/nox151 · 2018 · External reference
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy
10.1093/neuonc/nox154 · 2018 · External reference
An integrative approach for building personalized gene regulatory networks for precision medicine
10.1186/s13073-018-0608-4 · 2018 · External reference
10.1038/520609a
10.1038/520609a · External reference
Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation
10.1016/j.biopha.2019.109810 · 2020 · External reference
